Evidence map›Paper›PMID 38754907›Full record

ArticleBMJ open respiratory research2024

When to reinvite initially ineligible populations for targeted lung cancer screening?

Patrick Goodley, Philip A J Crosbie, Matthew Sperrin, Zoe Merchant, Richard Booton, Haval Balata

Abstract read
In one paragraph

Article in BMJ open respiratory research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Patrick GoodleyManchester Thoracic Oncology Centre, Manchester University NHS Foundation Trust, Manchester, UK.ORCID http://orcid.org/0000-0002-5729-2548
Philip A J CrosbieManchester Thoracic Oncology Centre, Manchester University NHS Foundation Trust, Manchester, UK.ORCID http://orcid.org/0000-0001-8941-4813
Matthew SperrinDivision of Informatics Imaging and Data Sciences, The University of Manchester, Manchester, UK.ORCID http://orcid.org/0000-0002-5351-9960
Zoe MerchantManchester Thoracic Oncology Centre, Manchester University NHS Foundation Trust, Manchester, UK.ORCID http://orcid.org/0000-0001-6217-2973
Richard BootonManchester Thoracic Oncology Centre, Manchester University NHS Foundation Trust, Manchester, UK.ORCID http://orcid.org/0000-0003-4512-2899
Haval BalataManchester Thoracic Oncology Centre, Manchester University NHS Foundation Trust, Manchester, UK haval.balata@manchester.ac.uk.ORCID http://orcid.org/0000-0002-8596-9376

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTargeted low-dose CT lung cancer screening reduces lung cancer mortality. England's Targeted Lung Health Check programme uses risk prediction tools to determine eligibility for biennial screening among people with a smoking history aged 55-74. Some participants initially ineligible for lung cancer screening will later become eligible with increasing age and ongoing tobacco exposure. It is, therefore, important to understand how many people could qualify for reinvitation, and after how long, to inform implementation of services.

methodsWe prospectively predicted future risk (using Prostate, Lung, Colorectal and Ovarian trial's risk model (PLCO

resultsApproximately a quarter eventually become eligible, with those with the lowest baseline risks unlikely to ever become eligible. Time-to-eligibility is shorter for participants with higher baseline risk, increasing age and ongoing smoking status. At a PLCO DISCUSSION: Predicting which participants may become eligible, and when, during a screening programme can help inform reinvitation strategies and service planning. Those with risk scores closer to the eligibility threshold, particularly people who continue to smoke, will reach eligibility in subsequent rounds while those at the lowest risk may be discharged from the programme from the outset.

Indexed as

Early Detection of CancerLung NeoplasmsAgedEligibility DeterminationEnglandFemaleHumansMaleMass ScreeningMiddle AgedProspective StudiesRisk AssessmentRisk FactorsSmokingTomography, X-Ray ComputedClinical EpidemiologyLung CancerMass Screening

Identifiers

PMID38754907
PMCPMC11097831

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.